Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Mar 4th 2020, Crypto Chartbook – Sitting on your hands

Sitting on your hands More important than making money is not losing it. If you lose fifty percent of your investment money, you need to make one hundred percent profits, just to break even. This counter intuitive principle works against you. If you trade a normally slow ...

Mar 9th 2020, Crypto Chartbook: Margin call – the cash trap

Margin call – the cash trap During the last two week all major indices like S&P 500, Dow Jones, NASDAQ, DAX and others dropped by more than 10% in what is considered one of the worst weeks in trading. This Monday morning the bloodbath continues. But why did gold and Bitco...

The Mega Opportunity in Organic Soil Health

(Click image to play video) From rising costs, to rising populations, to the COVID-19 pandemic and its impact on the global food supply, there are new issues around growing production that few companies are prepared for. This is where EarthRenew Inc. ( CS...

Myovant Sciences Shares Up 110% on Phase 3 Advanced Prostate Cancer Data

Shares of Myovant Sciences opened 120% higher today after the firm reported a 97% response rate in its Phase 3 HERO Study of oral Relugolix in men with advanced prostate cancer. In the study, Relugolix achieved all six key secondary endpoints and the firm expects to submit a N...

Coronavirus Propels Telemedicine into the Spotlight

Summary: Coronavirus could be the game changer that propels telemedicine into the mainstream. Virtual clinical services have been around since the '90s but had failed to catch on. Now, a concerted effort by healthcare providers, insurance companies, the federal government...

Confusion Reigns (Or What to Do When Nothing Makes Sense)

As I reach end-of-week, end-of-month book-squaring, where all of my urgent e-mails and all of my myopic missives and all of my topical tweets are summarized in once terse and quite concise "Monthly P&L," I am astounded at the most recent example of how masterfully the Gol...

My Second-Worst Nightmare

It was only a few hours ago that I was cruising through a lovely early-autumn Friday afternoon preparing for one of the last weekends at the marina for the 2019 season when I came across the much-heralded (and often misinterpreted) COT report. I was on the way up the ea...

Silver: The HARD Look

In this week's commentary, I am going to respond to the rash of end-of-the-world emails and terror-stricken texts that bombarded me after the BLS reported a better-than-expected Non-Farm Payrolls number Friday that sent stocks screaming higher and the precious metals in...

Freegold Ventures Climbs Golden Summit

Brad Aelicks: Diligence Report 2020.06.09 On May 6th 2020 Freegold Ventures (TSX.V:FVL) released results from hole #1 into a new zone on its Golden Summit property situated 18km NE of Fairbanks Alaska and just 5km from Kinross Gold’s Fort Knox deposit. The ...

Junior Explorer Moves Forward in 'Prime Gold Real Estate'

Gatling Exploration Inc. (GTR:TSX.V; GATGF:OTCQX) Trades Toronto: GTR US OTC: GATGF Shares Outstanding: 47.5 million Price 10/25/19: US$0.356; 12/5/19 US$0.32 Market Cap: ~US$17 million Cash: ~$4 million Gold Resource (A...
1 2